BCL6 and cancer: BCL6, BCL6 transcription repressor or B-cell CLL/lymphoma 6, is a sequence-specific DNA-binding protein that inhibits transcription through interactions with various corepressors (39) and has been extensively studied in autoimmune diseases and cancer (40).